Neisseria mutants, lipooligosaccharides and immunogenic compositions
AssigneeEmory University
InventorsDavid S. Stephens, Charlene Marree Kahler
Life of this patent
Estimating the term…
Loading patent…
AssigneeEmory University
InventorsDavid S. Stephens, Charlene Marree Kahler
Estimating the term…
Provided herein are mutant strains of Neisseria meningitidis which produce lipooligosaccharide (LOS) differing from the wild-type LOS in structure as well as the mutant LOS molecules and immunogenic compositions containing truncated LOS molecules from a Neisseria strain containing a genetically stable in a gene selected from the group consisting of genes encoding .alpha.-1,2-N-acetylglucosamine transferase and a gene homology to an Escherichia coli gene encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase. N. meningitidis NMB-559 harbors an insertion mutation in the gene encoding .alpha.-1, 2-N-acetylglucosamine transferase, and N. meningitidis NMB-469 harbors an insertion mutation in an nlaB gene, the protein product of which has significant amino acid sequence homology to the E. coli gene encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase.
A genetically stable mutant of a neisserial strain in which a gene selected from the group consisting of a gene encoding .alpha.-1,2-N-acetylglucosamine transferase which has been inactivated and an nlaB gene has been inactivated.
Dependencies are inferred from the claim text.